71 results
S-8
VKTX
Viking Therapeutics Inc
22 May 24
Registration of securities for employees
4:33pm
purchase period.
Table 2: Fee Offset Claims and Sources
Registrant or Filer Name
Form or Filing Type
File Number
Initial Filing Date
Filing Date
Fee … Offset Claimed
Security Type Associated with Fee Offset Claimed
Security Title Associated with Fee Offset Claimed
Unsold Securities Associated with Fee
8-K
EX-99.1
VKTX
Viking Therapeutics Inc
24 Apr 24
Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
4:05pm
to increased expenses related to stock-based compensation, salaries and benefits and services provided by third-party consultants, partially offset … , noted previously, partially offset by increased interest income, compared to the same period in 2023.
At March 31, 2024, Viking held cash, cash
8-K
EX-99.1
yamc5958 fz68
7 Feb 24
Viking Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
4:09pm
8-K
EX-99.1
u7w dt0lv
25 Oct 23
Viking Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:24pm
S-3ASR
nwhd1x
26 Jul 23
Automatic shelf registration
5:26pm
8-K
EX-99.1
1khr3z7q5j
26 Jul 23
Viking Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:23pm
8-K
EX-99.1
m0km52jv7fgm366ll
26 Apr 23
Viking Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:06pm
8-K
EX-99.1
3pd6ggba67uff2
26 Oct 22
Viking Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:32pm
8-K
EX-99.1
ir3a9cxprwdhzqcmt9
27 Jul 22
Viking Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:11pm
8-K
EX-99.1
9lqt 9qhsrhlqggvzmbf
27 Apr 22
Viking Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:44pm